HealthEdge Investment Partners announced that it has completed the sale of LifeSync, a developer, manufacturer, and marketer of disposable and reusable patient monitoring devices and connections sold to hospitals and other high acuity settings. LifeSync was acquired by Amphenol (APH).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APH:
- Third Point buys Capital One, cuts Microsoft in Q4
- Amphenol Corporation’s Financial Stability Threatened by Market Volatility
- Amphenol Bolsters Market Position with Strategic Acquisitions
- Amphenol Corp’s Q4 2024 Earnings: Record Growth Amid Challenges
- Trump Trade: President blasts EU regulators for targeting U.S. tech companies